Speciality: All Speciality
Description:
A warm welcome to all the medical professionals in this interesting session on Recent updates in IL-17i in Rheumatology and Dermatology
Recent advancements in the use of IL-17 inhibitors (IL-17i) have shown significant promise in the fields of rheumatology and dermatology. IL-17 inhibitors target the inflammatory cytokine IL-17, which plays a crucial role in autoimmune diseases such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. The introduction of new IL-17i treatments, such as secukinumab and ixekizumab, has led to improved outcomes for patients suffering from these chronic conditions.
In rheumatology, IL-17 inhibitors have demonstrated effectiveness in reducing joint inflammation and pain in patients with psoriatic arthritis and ankylosing spondylitis. Clinical trials have shown that these medications not only alleviate symptoms but also slow disease progression, offering a better quality of life for patients. The ability of IL-17 inhibitors to target specific pathways involved in inflammation marks a significant advancement over traditional treatments, which often have broader immunosuppressive effects.
Therefore, get an overall knowledge of updated recent updates in IL-17i in rheumatology and dermatology
See More Webinars @ Hidoc Webinars
1.
Patients face high out-of-pocket costs after incident cancer diagnosis
2.
In a study, immune detection of oral cancers is linked to obesity.
3.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
4.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
5.
Common intracellular toxin could help fight leukemia
1.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
2.
The Latest Research on Chronic Granulomatous Disease and Promising New Treatments
3.
Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources
4.
Florinef: Understanding Its Uses and Side Effects
5.
Uncovering the Subtle Signs of Leukemia: A Guide to Early Detection
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
3.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation